BioCardia Inc.
NASDAQ:BCDA
| Market Cap (Intraday) | 71.22M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $4.33 |
| 50-Day MA | $3.91 |
| 200-Day MA | $3.39 |
BioCardia Inc. Stock, NASDAQ:BCDA
125 Shoreway Road, Suite B, San Carlos, California 94070
United States of America
Phone: +1.650.226.0120
Number of Employees: 29
Description
BioCardia, Inc. operates as a clinical-stage regenerative medicine company. It develops novel therapeutics for cardiovascular diseases. The firm offers proprietary comprehensive biotherapeutic solutions for cardiovascular disease under the CardiAMP and CardiALLO brand. It operates in only one business segment, which is a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. The company was founded on January 12, 1994 and is headquartered in San Carlos, CA.